SCHEMBL3672296

SCHEMBL3672296

COc1ccccc1CN(CCC1CC(n2c(=O)[nH]c3ccccc32)CCN1C(=O)O)Cc1ccccc1.O=C(O)N1CCC(Nc2ccccc2)C(CCCc2ccccc2)[C@H]1N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.37
▸ DRD4 P21917 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ BCHE P06276 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ HSD11B1 P28845 3/20 0.35
▸ PAX8 Q06710 2/20 0.35
▸ OPRM1 P35372 5/20 0.35
▸ OPRL1 P41146 1/20 0.35
▸ PLD1 Q13393 4/20 0.34
▸ PLD2 O14939 2/20 0.34
▸ OPRK1 P41145 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ PMP22 Q01453 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1838186 0.86 DRD2 (0.47) DRD2DRD4DRD3BCHEACHE
SCHEMBL1838940 0.79 OPRM1 (0.42) DRD2DRD4DRD3BCHEACHE
SCHEMBL1833975 0.78 OPRM1 (0.47) DRD2DRD4DRD3BCHEACHE
SCHEMBL1833681 0.78 OPRM1 (0.52) BCHEACHEOPRM1OPRL1PLD1
SCHEMBL1836059 0.77 OPRM1 (0.55) DRD2DRD4DRD3BCHEACHE
SCHEMBL1835710 0.76 OPRM1 (0.58) DRD2DRD4DRD3BCHEACHE
SCHEMBL1836591 0.75 PLD1 (0.51) DRD2DRD4DRD3BCHEACHE
SCHEMBL1831703 0.75 OPRM1 (0.47) DRD2DRD4DRD3BCHEACHE
SCHEMBL3400375 0.75 OPRM1 (0.47) DRD2DRD4DRD3BCHEACHE
SCHEMBL3403017 0.75 OPRM1 (0.50) DRD2DRD4DRD3BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback